| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/15/2006 | US20060128713 (6-Chloro-3,4-dihydro-1H-benzo[4,5]thieno[2,3-c]pyridin-2-yl)-(2-isopropoxy-5-methanesulfonyl-phenyl)-methanone; glyicne transporter 1 (GlyT-1) and N-methyl-D-aspartate (NMDA) receptors inhibitor; psychoses, schizophrenia, attention deficit disorders, Alzheimer's disease; cognition activator |
| 06/15/2006 | US20060128710 Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof |
| 06/15/2006 | US20060128709 N-(4-Chlorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1; angiogenesis inhibitors; anticancer agents; diseases associated with signal transduction pathways operating through growth factor receptors |
| 06/15/2006 | US20060128707 Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors |
| 06/15/2006 | US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/15/2006 | US20060128693 Pyrrolobenzodiazepines |
| 06/15/2006 | US20060128692 Non nucleoside reverse transcriptase inhibitors |
| 06/15/2006 | US20060128691 gamma-aminobutyric acid GABA receptors inverse agonists ; Alzheimer's disease, cognition enhancers; 10-methyl-9H-imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine |
| 06/15/2006 | US20060128683 Novel use of porphyrin derivatives |
| 06/15/2006 | US20060128638 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 06/15/2006 | US20060124921 Compound with indolocarbazole moieties and devices containing such compound |
| 06/15/2006 | CA2589127A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 06/15/2006 | CA2588761A1 2,4(4,6)pyrimidine derivatives |
| 06/15/2006 | CA2588760A1 Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | CA2587936A1 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 06/14/2006 | EP1669071A1 Pyrrolotriazine inhibitors of kinases |
| 06/14/2006 | EP1668985A2 Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
| 06/14/2006 | EP1668015A2 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof |
| 06/14/2006 | EP1668014A2 Fused heterocyclic compounds as serotonin receptor modulators |
| 06/14/2006 | EP1668013A1 Pyrazolopyrrole derivatives as protein kinase inhibitors |
| 06/14/2006 | EP1668012A1 Method for preparing cucurbiturils |
| 06/14/2006 | EP1667965A2 Bridged macrocyclic module compositions |
| 06/14/2006 | EP1667685A1 Quinazoline potassium channel inhibitors |
| 06/14/2006 | EP1667524A2 Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 06/14/2006 | EP1497292B1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1377577B1 Pyrrole derivates for treating cytokine mediated diseases |
| 06/14/2006 | EP1017675B1 Highly lipophilic camptothecin derivatives |
| 06/14/2006 | DE19526503B4 Verfahren zur Herstellung von Hexanitrohexaazaisowurtzitan A process for preparing hexanitrohexaazaisowurtzitane |
| 06/14/2006 | DE112004001615T5 Zaleplon-Synthese Zaleplon synthesis |
| 06/14/2006 | CN1788009A Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/14/2006 | CN1788006A Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1787823A 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/14/2006 | CN1786001A Composition stable blood porphrin derivative, its preparation method and injection agent |
| 06/14/2006 | CN1259320C Application of alkaloid in cephalataxus fortunei esters for preventing and curing nematodiasis of plants |
| 06/14/2006 | CN1259044C Bone metabolism improving agents |
| 06/13/2006 | USRE39128 Antibacteria drug; respiratory system disorders; otitis |
| 06/13/2006 | US7061791 High density molecular memory device |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060843 Electroluminescent devices comprising diketopyrrolopyrroles |
| 06/13/2006 | US7060840 Using a chiral, non-racemic tertiary amine catalyst,e.g., one containing a 1-azabicyclo(2.2.2)octane moiety or a 1,4-diazabicyclo(2.2.2)octane moiety. |
| 06/13/2006 | US7060832 Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R” |
| 06/13/2006 | US7060830 Central nervous system disorders; antibiotics; viricides; antitumor agents; psychological disorders |
| 06/13/2006 | US7060824 Pyrrolotriazolopyrimidinone derivatives |
| 06/13/2006 | US7060823 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 06/13/2006 | US7060818 Synthesis of macrocyclic tetraamido compounds and new metal insertion process |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060290 Phosphocholine linked prodrug derivatives |
| 06/13/2006 | US7060254 Aerosol; heating thin film on solid support; vaporization with air flow |
| 06/13/2006 | CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006060225A2 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
| 06/08/2006 | WO2006058879A1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 06/08/2006 | WO2006044958A8 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 06/08/2006 | WO2006044504A8 Cgrp receptor antagonists |
| 06/08/2006 | WO2006019940A3 Pyrrolo(oxo)quinolines as 5ht ligands |
| 06/08/2006 | US20060122393 Process for the manufacture of fused piperazin-2-one derivatives |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122389 Pyrazolotriazines as kinase inhibitors |
| 06/08/2006 | US20060122385 cyclization of a 1,4-benzodiazepine with cyclopentene. in a diels-alders reaction to give a decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline, then resolving to form diastereomeric salts and dimer impurities; neuroleptic and dietetic agents |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122219 Use of flumazenil in the production of a medicament for the treatment of cocaine dependency |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122185 Bicyclic inhibitors of Rho kinase |
| 06/08/2006 | US20060122178 Compounds having activity as inhibitors of apoptosis |
| 06/08/2006 | US20060122172 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
| 06/08/2006 | US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |
| 06/08/2006 | US20060122163 adding temozolomide with dissolution enhancing agent is selected from L-histidine, L-threonine, L-asparagine, L-serine, and L-glutamine; freeze drying |
| 06/08/2006 | US20060122154 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/08/2006 | US20060121503 Chemically reactive carbocyanine dyes that are intramolecularly connected or crosslinked between the 1-position and 3'-position by a polyamino acid linker; reduction of the ground state aggregation caused by steric hindrance of the crosslinking results in more fluorescent on proteins and nucleic acids |
| 06/08/2006 | CA2588961A1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 06/08/2006 | CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666468A1 Crf antagonists and heterobicyclic compounds |
| 06/07/2006 | EP1666465A1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor |
| 06/07/2006 | EP1664092A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 06/07/2006 | EP1664053A1 Substituted heterocyclic compounds and methods of use |
| 06/07/2006 | EP1664052A1 Fused heterocycles as inhibitors of glutamate racemase (muri) |
| 06/07/2006 | EP1664051A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 06/07/2006 | EP1664050A2 Neuroprotective bicyclic compounds and pharmaceutical compositions containing them |
| 06/07/2006 | EP1664049A1 Synthesis of protected pyrrolobenzodiazepines |
| 06/07/2006 | EP1664045A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors |
| 06/07/2006 | EP1664043A2 Compositions useful as inhibitors of protein kinases |
| 06/07/2006 | EP1664042A1 IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS |
| 06/07/2006 | EP1664040A1 Gyrase inhibitors |
| 06/07/2006 | EP1664023A1 Sustituted isoquinoline derivatives and methods of use |
| 06/07/2006 | EP1663999A2 Inhibitors of phosphodiesterase type-iv |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663254A2 Anti-inflamatory phosphonate conjugates |
| 06/07/2006 | EP1663237A2 Fused ring heterocycles as potassium channel modulators |
| 06/07/2006 | EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| 06/07/2006 | EP1662877A1 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests |
| 06/07/2006 | EP1662876A2 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |